Aurea Health · Brand Positioning · Session 4

Competitive Radar Maps

AI-Accelerated Entrepreneurship Practicum · Vanderbilt Owen MBA · Spring 2026

Radar Map 01 — Patient Experience

Proactivity vs. Information Clarity

How well does each platform help the individual anticipate disease and understand their own health data?

Competitors

Aurea Health
Traditional PCP (Value-Based Care)
Consumer Wearables (Apple Watch / Fitbit)

Attribute Scores (1–10)

Early Warning (Proactivity)
AH:9 · PCP:3 · CW:6
Information Clarity
AH:9 · PCP:4 · CW:5
Personalization Depth
AH:9 · PCP:5 · CW:5
Daily Usability
AH:8 · PCP:2 · CW:9
Clinical Actionability
AH:9 · PCP:7 · CW:3
User Autonomy
AH:9 · PCP:3 · CW:7
Key Insight: Consumer wearables win on usability but lack clinical actionability. Traditional PCP provides clinical depth but fails on proactivity and autonomy. Aurea dominates the intersection: continuous, clear, and clinically actionable.
Radar Map 02 — System Architecture

Data Continuity vs. Clinical Rigor

How well does each platform generate longitudinal data and translate it into clinically rigorous outputs?

Competitors

Aurea Health
Pharma PSPs (Patient Support Programs)
Niche Metabolic Apps (Levels, Zoe)

Attribute Scores (1–10)

Longitudinal Continuity
AH:9 · PSP:5 · NM:7
Clinical Rigor
AH:8 · PSP:9 · NM:5
Attribution Independence
AH:10 · PSP:2 · NM:8
RWE Generation Capability
AH:9 · PSP:7 · NM:3
Pre-Diagnosis Reach
AH:9 · PSP:1 · NM:8
Cross-Setting Data Integration
AH:8 · PSP:4 · NM:4
Key Insight: Pharma PSPs have clinical rigor but zero pre-diagnosis reach — they only activate post-Rx. Niche metabolic apps reach the pre-diagnosis user but can't generate RWE. Aurea uniquely bridges both, with attribution-independent continuity.
Radar Map 03 — Market Integration

Ecosystem Fluidity vs. Incentive Alignment

How well does each player integrate into the broader healthcare ecosystem and align incentives with patient-first outcomes?

Competitors

Aurea Health
Fee-For-Service / Traditional System
Value-Based Care ACOs

Attribute Scores (1–10)

Ecosystem Routing Fluidity
AH:9 · FFS:2 · VBC:5
Patient-First Incentive Alignment
AH:9 · FFS:2 · VBC:6
Pharma Partnership Capability
AH:9 · FFS:3 · VBC:4
Employer/Payvidor Integration
AH:8 · FFS:4 · VBC:7
Prevention ROI Capture
AH:9 · FFS:1 · VBC:5
Data Monetization Infrastructure
AH:9 · FFS:1 · VBC:3
Key Insight: Fee-for-service has zero incentive alignment. VBC ACOs improve on alignment but suffer from the four structural break points. Aurea captures prevention ROI through a parallel incentive architecture — pharma, employers, and payvidors pay directly for the outcomes the reimbursement system refuses to fund.
Aurea Health · Brand Positioning Memo · Session 4 · AI-Accelerated Entrepreneurship Practicum · Vanderbilt Owen MBA Spring 2026